Association of fasting glucagon-like peptide-1 and glucose dependent insulinotropic polypeptide with dyslipidemia in newly diagnosed diabetes

ConclusionThe effect of GIP and GLP-1 measures on dyslipidemia were substantially different among NDD participants in our population. In the NDD group, GLP-1 is significantly moderately associated with dyslipidemia compared to GIP.

Source: International Journal of Diabetes in Developing Countries - January 7, 2022 Category: Endocrinology Source Type: research